These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19037815)

  • 1. Acute meningoencephalitis due to human immunodeficiency virus type 1 infection in 13 patients: clinical description and follow-up.
    del Saz SV; Sued O; Falcó V; Agüero F; Crespo M; Pumarola T; Curran A; Gatell JM; Pahissa A; Miró JM; Ribera E
    J Neurovirol; 2008 Nov; 14(6):474-9. PubMed ID: 19037815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Herpes simplex and lymphocytic choriomeningitis viruses in infections of the central nervous system--clinical and cerebrospinal fluid characteristics].
    Turkulov V; Madle-Samardzija N; Ilić A; Vukadinov J; Canak G
    Med Pregl; 1998; 51(9-10):436-40. PubMed ID: 9863335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute meningoencephalitis in chronic human immunodeficiency virus (HIV) infection: putative central nervous system escape of HIV replication.
    Wendel KA; McArthur JC
    Clin Infect Dis; 2003 Oct; 37(8):1107-11. PubMed ID: 14523776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human adenovirus meningoencephalitis: a 3-years' overview.
    Vidal LR; de Almeida SM; Cavalli BM; Dieckmann TG; Raboni SM; Salvador GLO; Pereira LA; Rotta I; Nogueira MB
    J Neurovirol; 2019 Aug; 25(4):589-596. PubMed ID: 31102186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroencephalography findings in adult patients with West Nile virus-associated meningitis and meningoencephalitis.
    Gandelman-Marton R; Kimiagar I; Itzhaki A; Klein C; Theitler J; Rabey JM
    Clin Infect Dis; 2003 Dec; 37(11):1573-8. PubMed ID: 14614682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study.
    Kremer S; Lersy F; Anheim M; Merdji H; Schenck M; Oesterlé H; Bolognini F; Messie J; Khalil A; Gaudemer A; Carré S; Alleg M; Lecocq C; Schmitt E; Anxionnat R; Zhu F; Jager L; Nesser P; Mba YT; Hmeydia G; Benzakoun J; Oppenheim C; Ferré JC; Maamar A; Carsin-Nicol B; Comby PO; Ricolfi F; Thouant P; Boutet C; Fabre X; Forestier G; de Beaurepaire I; Bornet G; Desal H; Boulouis G; Berge J; Kazémi A; Pyatigorskaya N; Lecler A; Saleme S; Edjlali-Goujon M; Kerleroux B; Constans JM; Zorn PE; Mathieu M; Baloglu S; Ardellier FD; Willaume T; Brisset JC; Caillard S; Collange O; Mertes PM; Schneider F; Fafi-Kremer S; Ohana M; Meziani F; Meyer N; Helms J; Cotton F
    Neurology; 2020 Sep; 95(13):e1868-e1882. PubMed ID: 32680942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute meningoencephalitis in a patient with primary HIV infection].
    Penado Nadela S; Casas Mde P; Villanueva Morgade L; Jove Castelo MJ
    Enferm Infecc Microbiol Clin; 2006 Apr; 24(4):290-1. PubMed ID: 16725097
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.
    Christo PP; Greco DB; Aleixo AW; Livramento JA
    BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing cytomegalovirus meningoencephalitis from other viral central nervous system infections.
    Handley G; Pankow S; Bard JD; Yee R; Nigo M; Hasbun R
    J Clin Virol; 2021 Sep; 142():104936. PubMed ID: 34352616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
    Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
    Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Structured therapeutic interruption in patients infected with HIV-1 experiencing a block in their antiretroviral treatment: preliminary results].
    Rey D; Schmitt MP; Hess-Kempf G; Krantz V; Partisani M; Bernard-Henry C; Lang JM
    Pathol Biol (Paris); 2001 Sep; 49(7):559-66. PubMed ID: 11642019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Retrospective Cohort Study of Lesion Distribution of HIV-1 Infection Patients With Cryptococcal Meningoencephalitis on MRI: Correlation With Immunity and Immune Reconstitution.
    Xia S; Li X; Shi Y; Liu J; Zhang M; Gu T; Pan S; Song L; Xu J; Sun Y; Zhao Q; Lu Z; Lu P; Li H
    Medicine (Baltimore); 2016 Feb; 95(6):e2654. PubMed ID: 26871791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Laboratory testing including CD4 T-cell count and determination of viral load to evaluate the impact of first line antiretroviral treatment at 6 months in adults in Benin].
    Ogouyemi-Hounto A; Zannou D; Metodakou D; Lafia B; Gomez V; Akinocho E
    Med Trop (Mars); 2010 Feb; 70(1):100. PubMed ID: 20337131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency Virus.
    Hellmuth J; Muccini C; Colby DJ; Kroon E; de Souza M; Crowell TA; Chan P; Sacdalan C; Intasan J; Benjapornpong K; Tipsuk S; Puttamaswin S; Chomchey N; Valcour V; Sarnecki M; Tomaka F; Krebs SJ; Slike BM; Jagodzinski LL; Dumrongpisutikul N; Sailasuta N; Samboju V; Michael NL; Robb ML; Vasan S; Ananworanich J; Phanuphak P; Phanuphak N; Paul R; Spudich S
    Clin Infect Dis; 2021 Oct; 73(7):e1885-e1892. PubMed ID: 32916708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8 encephalitis in HIV-infected patients receiving cART: a treatable entity.
    Lescure FX; Moulignier A; Savatovsky J; Amiel C; Carcelain G; Molina JM; Gallien S; Pacanovski J; Pialoux G; Adle-Biassette H; Gray F
    Clin Infect Dis; 2013 Jul; 57(1):101-8. PubMed ID: 23515205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study.
    Edén A; Nilsson S; Hagberg L; Fuchs D; Zetterberg H; Svennerholm B; Gisslén M
    J Infect Dis; 2016 Dec; 214(12):1822-1825. PubMed ID: 27683820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control.
    Assoumou L; Weiss L; Piketty C; Burgard M; Melard A; Girard PM; Rouzioux C; Costagliola D;
    AIDS; 2015 Sep; 29(15):2003-7. PubMed ID: 26355572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 meningoencephalitis in patients on effective HAART.
    Lafeuillade A; Cheret A; Hittinger G; Poggi C
    HIV Clin Trials; 2009; 10(3):200-2. PubMed ID: 19632959
    [No Abstract]   [Full Text] [Related]  

  • 19. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
    Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
    J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of hepatitis C and hepatitis G virus co-infection on viral and cellular dynamics in patients infected with human immunodeficiency virus following interruption of highly active anti-retroviral therapy.
    Soriano-Sarabia N; Abad MA; Vallejo A; Gutiérrez S; Leal M
    Clin Microbiol Infect; 2006 Mar; 12(3):290-3. PubMed ID: 16451419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.